Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

96.72
+0.41000.43%
Post-market: 96.720.00000.00%19:30 EDT
Volume:367.57K
Turnover:35.62M
Market Cap:6.28B
PE:-6.87
High:97.85
Open:96.31
Low:95.49
Close:96.31
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:0.72
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-602.59
PE(LYR):-205.79

Loading ...

Mirum Pharmaceuticals Inc: Potential Bla Submission and Launch in U.S. for Azure-1 and Azure-4 Expected in 2027

THOMSON REUTERS
·
Mar 05

Stock Track | Mirum Pharmaceuticals Soars 5.07% Intraday After Evercore Raises Price Target on Upcoming Trial Data

Stock Track
·
Mar 05

Mirum Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Mar 05

BUZZ-Mirum Pharma gains after Evercore raises PT on liver drugs potential

Reuters
·
Mar 04

Mirum Pharmaceuticals (MIRM) Narrowing Losses Challenge Bearish Profitability Narratives In FY 2025 Results

Simply Wall St.
·
Feb 27

Mirum Pharmaceuticals Down Over 14%, on Pace for Largest Percent Decrease Since December 2023 -- Data Talk

Dow Jones
·
Feb 27

Stock Track | Mirum Pharmaceuticals Plummets 11.13% Intraday Amid Mixed Analyst Sentiment and RBC Price Target Cut

Stock Track
·
Feb 26

Mirum Pharmaceuticals sees FY26 global net product sales $630M-$650M

TIPRANKS
·
Feb 26

Mirum Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Feb 26

Stock Track | Mirum Pharmaceuticals Plunges 5.17% in Pre-Market Amid Mixed Analyst Price Target Adjustments

Stock Track
·
Feb 26

Morgan Stanley Raises Price Target on Mirum Pharmaceuticals to $130 From $123, Keeps Overweight Rating

MT Newswires Live
·
Feb 26

Mirum Pharmaceuticals : Morgan Stanley Raises Target Price to $130.00 From $123.00

THOMSON REUTERS
·
Feb 26

Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN), Mirum Pharmaceuticals (MIRM) and Revolution Medicines (RVMD)

TIPRANKS
·
Feb 26

BRIEF-Mirum Pharmaceuticals Files For Offering Of Up To 8.96 Million Shares Of Common Stock By The Selling Stockholders

Reuters
·
Feb 26

Mirum Pharmaceuticals Inc Files for Offering of up to 8.96 Mln Shares of Common Stock by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Feb 26

Earnings Flash (MIRM) Mirum Pharmaceuticals Posts Q4 Revenue $148.9M, vs. FactSet Est of $142.5M

MT Newswires Live
·
Feb 26

Mirum Pharmaceuticals Q4 Sales $148.932M Beat $141.806M Estimate

Benzinga Earnings
·
Feb 26

Mirum Pharmaceuticals 2025 sales rise

Reuters
·
Feb 26

BRIEF-Mirum Pharmaceuticals Q4 Operating Expenses USD 153.499 Million

Reuters
·
Feb 26

Mirum Pharmaceuticals Inc: Volixibat Vistas Study in Psc Topline Data Expected Q2 2026

THOMSON REUTERS
·
Feb 26